Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL) cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath MabCampath and Campath-1H and in the treatment of multiple sclerosis as Lemtrada.
This page contains content from the copyrighted Wikipedia article "Alemtuzumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.